These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 9186154

  • 1. Immunization of HIV-infected adults with a three-dose series of inactivated Mycobacterium vaccae.
    Marsh BJ, Fordham von Reyn C, Arbeit RD, Morin P.
    Am J Med Sci; 1997 Jun; 313(6):377-83. PubMed ID: 9186154
    [Abstract] [Full Text] [Related]

  • 2. Immunization of healthy adult subjects in the United States with inactivated Mycobacterium vaccae administered in a three-dose series.
    von Reyn CF, Arbeit RD, Yeaman G, Waddell RD, Marsh BJ, Morin P, Modlin JF, Remold HG.
    Clin Infect Dis; 1997 May; 24(5):843-8. PubMed ID: 9142780
    [Abstract] [Full Text] [Related]

  • 3. Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis.
    Waddell RD, Chintu C, Lein AD, Zumla A, Karagas MR, Baboo KS, Habbema JD, Tosteson AN, Morin P, Tvaroha S, Arbeit RD, Mwinga A, von Reyn CF.
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S309-15. PubMed ID: 10875806
    [Abstract] [Full Text] [Related]

  • 4. Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial.
    Matee M, Lahey T, Vuola JM, Mtei L, Cole BF, Bakari M, Arbeit RD, Horsburgh CR, Pallangyo K, von Reyn CF.
    J Infect Dis; 2007 Jan 01; 195(1):118-23. PubMed ID: 17152015
    [Abstract] [Full Text] [Related]

  • 5. Cellular immune responses to mycobacteria in healthy and human immunodeficiency virus-positive subjects in the United States after a five-dose schedule of Mycobacterium vaccae vaccine.
    von Reyn CF, Marsh BJ, Waddell R, Lein AD, Tvaroha S, Morin P, Modlin JF.
    Clin Infect Dis; 1998 Dec 01; 27(6):1517-20. PubMed ID: 9868670
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomised trial of intradermal Mycobacterium vaccae or intradermal hepatitis B immunisation in children with HIV infection.
    Johnson D, Waddell RD, Pelton SI, Jaeger AS, Modlin JF, Yogev R, Morin P, Arbeit RD, von Reyn CF.
    Vaccine; 1999 Jun 04; 17(20-21):2583-7. PubMed ID: 10418906
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial.
    Vuola JM, Ristola MA, Cole B, Järviluoma A, Tvaroha S, Rönkkö T, Rautio O, Arbeit RD, von Reyn CF.
    AIDS; 2003 Nov 07; 17(16):2351-5. PubMed ID: 14571187
    [Abstract] [Full Text] [Related]

  • 9. Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.
    von Reyn CF, Mtei L, Arbeit RD, Waddell R, Cole B, Mackenzie T, Matee M, Bakari M, Tvaroha S, Adams LV, Horsburgh CR, Pallangyo K, DarDar Study Group.
    AIDS; 2010 Mar 13; 24(5):675-85. PubMed ID: 20118767
    [Abstract] [Full Text] [Related]

  • 10. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM, Galai N, Nelson KE, Astemborski J, Bonds M, Rizzo RT, Sheeley L, Vlahov D.
    Arch Intern Med; 1996 Apr 22; 156(8):889-94. PubMed ID: 8774208
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients.
    French MA, Mallal SA, Dawkins RL.
    AIDS; 1992 Nov 22; 6(11):1293-7. PubMed ID: 1472334
    [Abstract] [Full Text] [Related]

  • 13. Increased protection against bovine tuberculosis in the brushtail possum (Trichosurus vulpecula) when BCG is administered with killed Mycobacterium vaccae.
    Skinner MA, Keen DL, Parlane NA, Yates GF, Buddle BM.
    Tuberculosis (Edinb); 2002 Nov 22; 82(1):15-22. PubMed ID: 11914058
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preventive effects of Mycobacterium vaccae on HIV-associated tuberculosis: a systematic review.
    Chen Q, Yang X, Li Y, He X, Ma X, Ma L, Guo Z, Li L.
    J Evid Based Med; 2011 May 22; 4(2):122-9. PubMed ID: 23672702
    [Abstract] [Full Text] [Related]

  • 16. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV, Dubé MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Lavelle JP, White AC, Witt MD, Bozzette SA, McCutchan JA.
    N Engl J Med; 1996 Aug 08; 335(6):392-8. PubMed ID: 8676932
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Mycobacterium avium infection in HIV-infected patients: epidemiology, diagnosis, prevention and treatment].
    Schneider MM, Reiss P, Borleffs JC, Rozenberg-Arska M, Hoepelman IM.
    Ned Tijdschr Geneeskd; 1997 Jan 11; 141(2):80-3. PubMed ID: 9036351
    [Abstract] [Full Text] [Related]

  • 20. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
    Jung Y, Song KH, Choe PG, Park WB, Bang JH, Kim ES, Kim HB, Park SW, Kim NJ, Oh MD.
    Int J STD AIDS; 2017 Dec 11; 28(14):1426-1432. PubMed ID: 28592210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.